KFP
MRNA icon

KB Financial Partners’s Moderna MRNA Stock Holding History

KB Financial Partners’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-14
Closed -$2K – 598
2023
Q2 		$2K Buy
+14
New +$1.87K ﹤0.01% 548
2023
Q1 		– Sell
-29
Closed -$5K – 599
2022
Q4 		$5K Sell
29
-13
-31% -$2.13K ﹤0.01% 425
2022
Q3 		$5K Buy
42
+30
+250% +$4.55K ﹤0.01% 418
2022
Q2 		$2K Buy
+12
New +$1.72K ﹤0.01% 529

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

KB Financial Partners's MRNA Position: Q3 2023 in Review

KB Financial Partners sold out of Moderna (MRNA) in Q3 2023, closing a stake of 14 shares — an estimated $2K sold.

KB Financial Partners first reported a position in MRNA in Q2 2022 and held it in 4 quarters. The position peaked at $5K in Q4 2022. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • KB Financial Partners reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • KB Financial Partners sold 14 Moderna shares in Q3 2023, an estimated $2K.
  • KB Financial Partners first reported a position in Moderna in Q2 2022 and held it in 4 quarters.
  • KB Financial Partners's Moderna position peaked at $5K in Q4 2022.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on KB Financial Partners's 13F filing for Q3 2023, filed 15 Nov 2023.